A review of the psychometric properties of the Health of the Nation Outcome Scales (HoNOS) family of measures

Pirkis, Jane; Burgess, Philip; Kirk, Pia K; Dodson, Sarity; Coombs, Tim; Williamson, Michelle

doi:10.1186/1477-7525-3-76

Cited by 241 publications

(137 citation statements)

References 81 publications

Supporting

Mentioning

127

Contrasting

Unclassified

Order By: Relevance

“…Each item is scored on a 5-point scale: not a problem (score 0), minor problem requiring no action (score 1), mild problem but definitely present (score 2), moderately severe problem (score 3) and severe to very severe problem (score 4). [16][17][18][19] We recoded each subscale so as to create two dummy variables for each dimension: one dummy variable for minor problems (original HoNOS score of 1 given the value 1; all other original HoNOS scores given the value 0) and the second dummy variable for significant problems (original HoNOS scores of 2, 3 or 4 given the value 1; all other original HoNOS scores given the value 0).…”

Section: Measurementsmentioning

confidence: 99%

Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register

et al. 2016

View full text Add to dashboard Cite

ObjectivesTo examine links between clinical and other characteristics of people with Alzheimer's disease living in the community, likelihood of care home or hospital admission, and associated costs.DesignObservational data extracted from clinical records using natural language processing and Hospital Episode Statistics. Statistical analyses examined effects of cognition, physical health, mental health, sociodemographic factors and living circumstances on risk of admission to care home or hospital over 6 months and associated costs, adjusting for repeated observations.SettingCatchment area for South London and Maudsley National Health Service Foundation Trust, provider for 1.2 million people in Southeast London.ParticipantsEvery individual with diagnosis of Alzheimer's disease seen and treated by mental health services in the catchment area, with at least one rating of cognition, not resident in care home at time of assessment (n=3075).InterventionsUsual treatment.Main outcome measuresRisk of admission to, and days spent in three settings during 6-month period following routine clinical assessment: care home, mental health inpatient care and general hospital inpatient care.ResultsPredictors of probability of care home or hospital admission and/or associated costs over 6 months include cognition, functional problems, agitation, depression, physical illness, previous hospitalisations, age, gender, ethnicity, living alone and having a partner. Patterns of association differed considerably by destination.ConclusionsMost people with dementia prefer to remain in their own homes, and funding bodies see this as cheaper than institutionalisation. Better treatment in the community that reduces health and social care needs of Alzheimer's patients would reduce admission rates. Living alone, poor living circumstances and functional problems all raise admission rates, and so major cuts in social care budgets increase the risk of high-cost admissions which older people do not want. Routinely collected data can be used to reveal local patterns of admission and costs.

show abstract

Section: Measurementsmentioning

confidence: 99%

Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register

et al. 2016

View full text Add to dashboard Cite

show abstract

“…It was suggested that the scale could be subdivided into 4 subscales (‘behavioral problems’, ‘impairment’, ‘symptomatic problems’ and ‘social problems’). However, there is not really much evidence that subscale scores are reliable [14,16,25,26]. Therefore, we only used the HoNOS-D main score and single items for further calculations.…”

Section: Methodsmentioning

confidence: 99%

“…It consists of 12 items for the assessment of severity of mental illness, deals with symptoms and dysfunctions, and is designed to track change over time. Psychometric properties were found to be satisfactory for most of the items, but the authors of a review conclude that validity in psychiatric routine care warrants closer examination [14]. Firstly, we tried to replicate the findings from evaluations of the validity of HoNOS and the German version of HoNOS (HoNOS-D) [11,15,16] by examining its association with the CGI as an established routine outcome measure.…”

Section: Introductionmentioning

confidence: 99%

The Concurrent Validity and Sensitivity of Change of the German Version of the Health of the Nation Outcome Scales in a Psychiatric Inpatient Setting

et al. 2011

View full text Add to dashboard Cite

Background: The Health of the Nation Outcome Scales (HoNOS) were developed to assess the severity of a mental illness. They are used as outcome measures in different countries, and are meanwhile translated from the original English version into many languages, among others into German (HoNOS-D). We conducted a study in order to estimate the concurrent validity and sensitivity to change using clinical parameters as ICD-10 diagnoses, as well as the Clinical Global Impression Scale (CGI), and the Association for Methodology and Documentation in Psychiatry (AMDP) psychopathology scale, a frequently used psychopathological rating system, in a representative clinical sample. Sampling and Methods: Data on the three instruments (CGI, AMDP, HoNOS-D) were collected at admission and discharge of 100 psychiatric inpatients using a representative clinical sample. Experienced clinicians completed the CGI, AMDP and HoNOS-D. Descriptive and comparative data analyses were performed. We estimated the concurrent validity by calculating correlations between the HoNOS and other scales. Secondly, we examined the differences between HoNOS scores related to diagnoses and demographic parameters. Thirdly we calculated change criteria and outcome effect size for the HoNOS. Results: Even in a small clinical sample (n = 100), the HoNOS-D items are highly correlated with the corresponding AMDP syndromes (p < 0.003). The HoNOS-D score is associated with the CGI score (p < 0.01). Correlations of HoNOS symptoms, behavior and impairment items with AMDP syndromes as well as differences in diagnoses were appropriate and comprehensible as regards clinical content, and change on the HoNOS total score is statistically significant (t = 6.57, d.f. = 89, p < 0.0001). Conclusion: This study is the first to investigate the concurrent validity of HoNOS-D concerning psychopathology using the AMDP rating system in a clinical sample of patients with mental disorders in an inpatient setting. HoNOS-D can be recommended for routinely screening outcomes in inpatient psychiatric settings. Our analysis showed that HoNOS-D covers psychopathology corresponding to the AMDP rating system. A limitation of the study is that the study sample comprised only an inpatient population; there may well be differences compared to an outpatient sample.

show abstract

“…The HoNOSCA has demonstrated sensitivity to change during treatment and respectable concurrent validity [49]. Correlations between the HoNOSCA and parent reports of psychopathology have been modest, but this does not necessarily impugn the validity of the HoNOSCA given that parent and child reports of psychopathology often diverge.…”

Section: Discussionmentioning

confidence: 99%

The Efficacy of Antidepressants on Overall Well-Being and Self-Reported Depression Symptom Severity in Youth: A Meta-Analysis

Spielmans

Gerwig²

2014

Psychother Psychosom

View full text Add to dashboard Cite

Background: Recent meta-analyses of the efficacy of second-generation antidepressants for youth have concluded that such drugs possess a statistically significant advantage over placebo in terms of clinician-rated depressive symptoms. However, no meta-analysis has included measures of quality of life, global mental health, self-esteem, or autonomy. Further, prior meta-analyses have not included self-reports of depressive symptoms. Methods: Studies were selected through searching Medline, PsycINFO, and the Cochrane Central Register for Controlled Trials databases as well as GlaxoSmithKline's online trial registry. We included self-reports of depressive symptoms and pooled measures of quality of life, global mental health, self-esteem, and autonomous functioning as a proxy for overall well-being. Results: We found a nonsignificant difference between second-generation antidepressants and placebo in terms of self-reported depressive symptoms (k = 6 trials, g = 0.06, p = 0.36). Further, pooled across measures of quality of life, global mental health, self-esteem, and autonomy, antidepressants yielded no significant advantage over placebo (k = 3 trials, g = 0.11, p = 0.13). Discussion: Though limited by a small number of trials, our analyses suggest that antidepressants offer little to no benefit in improving overall well-being among depressed children and adolescents.

show abstract

A review of the psychometric properties of the Health of the Nation Outcome Scales (HoNOS) family of measures

Cited by 241 publications

References 81 publications

Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register

Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register

The Concurrent Validity and Sensitivity of Change of the German Version of the Health of the Nation Outcome Scales in a Psychiatric Inpatient Setting

The Efficacy of Antidepressants on Overall Well-Being and Self-Reported Depression Symptom Severity in Youth: A Meta-Analysis

Contact Info

Product

Resources

About